PressJune 11, 2024 Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink
PressJune 11, 2024 Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID
PressJune 7, 2024 Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD
PressJune 7, 2024 Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia
PressJune 7, 2024 Red Light Holland Announces Completion of Full Psilocybin Extraction Report with PharmAla
PressJune 5, 2024 Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PressJune 4, 2024 Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
PressJune 3, 2024 Filament Health Announces Warrant Exercise and Note Conversion by Negev Capital and Concurrent Private Placement of Common Shares to Benjamin Lightburn, Chief Executive Officer
PressJune 3, 2024 Filament Health Announces Authorization of Phase 2 Clinical Trial for PEX010 in the Treatment of Methamphetamine Use Disorder
PressJune 3, 2024 Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
PressJune 3, 2024 Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders
PressMay 31, 2024 atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
Health & ScienceMay 31, 2024 FSD Pharma Triumphs in Legal Dispute Against Former CEO Dr. Raza Bokhari
Health & ScienceMay 31, 2024 FTC’s Final Rule Amendment to the Health Breach Notification Rule and Its Implications
